Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

File(s)

PIIS0140673613622424.pdf (450.59 KB)

Published version

Show more

Author(s)

Chataway, J

Schuerer, N

Alsanousi, A

Chan, D

MacManus, D

more

Type

Journal Article

Date Issued

2014-06-28

URI

http://hdl.handle.net/10044/1/26298

DOI

https://dx.doi.org/10.1016/S0140-6736(13)62242-4

ISSN

0140-6736

Publisher

ELSEVIER SCIENCE INC

Start Page

2213

End Page

2221

Journal / Book Title

LANCET

Volume

383

Issue

9936

Copyright Statement

© Chataway et al. Open Access article distributed under the terms of CC BY.

License URL

Attribution 4.0 International

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338657600025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Medicine, General & Internal

General & Internal Medicine

MEDICINE, GENERAL & INTERNAL

CENTRAL-NERVOUS-SYSTEM

NITRIC-OXIDE SYNTHASE

CLINICAL-TRIALS

REDUCTASE INHIBITORS

AUTOIMMUNE-DISEASE

OUTCOME MEASURE

VOLUME CHANGES

DOUBLE-BLIND

INTERFERON

THERAPY

Publication Status

Published